Cargando…
Perioperative and Palliative Chemotherapy for Esophageal Cancer
Perioperative and palliative chemotherapy for esophageal carcinoma has undergone substantial changes in recent years. The implementation of trastuzumab in the treatment of HER2-positive advanced adenocarcinoma is a milestone as it marked the introduction of the first molecularly targeted treatment o...
Autores principales: | Behrens, Angelika, Ell, Christian, Lordick, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger Verlag für Medizin und Naturwissenschaften GmbH
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789901/ https://www.ncbi.nlm.nih.gov/pubmed/26989390 http://dx.doi.org/10.1159/000438470 |
Ejemplares similares
-
ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)
por: Hoeppner, Jens, et al.
Publicado: (2016) -
Diagnostics and Early Diagnosis of Esophageal Cancer
por: Meves, Volker, et al.
Publicado: (2015) -
Palliative Endoscopic Therapy of Esophageal Cancer
por: Rabenstein, Thomas
Publicado: (2015) -
Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy
por: Kim, Sungjin, et al.
Publicado: (2020) -
TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG)
por: Leong, Trevor, et al.
Publicado: (2015)